Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
8.69Price to Book
VS
Market
Sector
Industry
History
$ 5.87Close
$ 2.41 - $ 6.65 52-Week Range
Ticker Information
Ticker
EPRXCompany Name
EUPRAXIA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQEUPRAXIA PHARMACEUTICALS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EPRX - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 22.55M | $ 195.98M | 8.69 |
| 3/31/2025 | $ 28.6M | $ 145.55M | 5.09 |
| 12/31/2024 | $ 33.4M | $ 139.36M | 4.17 |
| 9/30/2024 | $ 9.52M | $ 112.67M | 11.84 |
| 6/30/2024 | $ 14.83M | $ 85.14M | 5.74 |
| 3/31/2024 | $ 19.54M | $ 103.31M | 5.29 |
| 12/31/2023 | $ 2.22M | $ 0 | 0 |
| 9/30/2023 | $ 17.04M | $ 0 | 0 |
Key Performance Insights, Last 5 Years
- EUPRAXIA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, EUPRAXIA PHARMACEUTICALS INC's average P/B has been 6.8.
- The median P/B for EUPRAXIA PHARMACEUTICALS INC during this period was 5.51
- EUPRAXIA PHARMACEUTICALS INC reached its highest P/B over the past 5 years at 11.84.
- The lowest P/B recorded by EUPRAXIA PHARMACEUTICALS INC in the same timeframe 4.17
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for EUPRAXIA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ 17.04M ]
(=) P/B [ 0 ] EPRX - Price to Book, Last 5 years
4.17
Minimum
Dec 31, 2024
11.84
Maximum
Sep 30, 2024
6.8
Average
5.51
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |